haloperidol decanoate has been researched along with Recrudescence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A | 1 |
| Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N | 1 |
| Chang, WH; Jann, MW; Lin, HN; Piao-Chien, C; Wei, FC | 1 |
| Youssef, HA | 1 |
| Eklund, K; Forsman, A | 1 |
| Cookson, JC | 1 |
| Altamura, CA; Colacurcio, F; De Novellis, F; Mauri, MC; Moro, AR | 1 |
2 review(s) available for haloperidol decanoate and Recrudescence
| Article | Year |
|---|---|
[Life threatening neuroleptic malignant syndrome due to olanzapine].
Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Electroconvulsive Therapy; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence | 2003 |
Dose response of prophylactic antipsychotics.
Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology | 1993 |
3 trial(s) available for haloperidol decanoate and Recrudescence
| Article | Year |
|---|---|
A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Patient Compliance; Prospective Studies; Recurrence; Schizophrenia; Treatment Outcome | 1996 |
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay; Recurrence; Schizophrenia | 1991 |
Side effects during long-term treatment with depot antipsychotic medication.
Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Parkinson Disease, Secondary; Psychomotor Agitation; Recurrence; Schizophrenia | 1991 |
2 other study(ies) available for haloperidol decanoate and Recrudescence
| Article | Year |
|---|---|
Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate.
Topics: Antipsychotic Agents; Chronic Disease; Female; Follow-Up Studies; Haloperidol; Humans; Ireland; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1991 |
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Recurrence; Schizophrenia | 1990 |